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Beta-ketothiolase deficiency, also known as mitochondrial acetoacetyl CoA thiolase (T2) deficiency, is not only one of the rarer but also possibly underdiagnosed inborn 
errors of metabolism. The first proven case was described 
in 1971 [1], after which more than 100 cases have been 
reported [2]. Incidence is said to be <1 in a million [3], but this 
low incidence may be partly due to underreporting due to the 
non-specific presentation of this disorder. Incidence in India is 
yet unknown. It is one of the few inborn errors of metabolism 
that has a favorable outcome if diagnosed early and preventive 
measures such as moderate protein restriction are taken along 
with prompt treatment of intercurrent illnesses. We present such 
a case in identical twins.
CASE REPORT
A male child (Twin A) was first brought to our hospital in 
May 2015, at the age of 1 year with fever, loose stools, severe 
dehydration, acidotic breathing, and altered sensorium. Before 
this episode, he had an uneventful perinatal period and was 
developmentally normal and growing well. He was treated in 
our pediatric intensive care unit for acute gastroenteritis with 
some dehydration. Arterial blood gas analysis showed severe 
metabolic acidosis which was corrected with bicarbonate 
infusion. His complete blood counts, urine and stool microscopy, 
and serum ammonia levels were normal. Urine for ketones was 
positive, blood glucose was low, and blood lactate was high. 
Metabolic screening was sent before discharge in view of the 
severity of acidosis and the presence of encephalopathy which 
was not correlating with the degree of dehydration. Tandem mass 
spectrometry was positive for increased levels of tiglycl carnitine, 
hydroxyls butyrylcarnitine, and hydroxyisovalerylcarnitine. 
Urine gas chromatography-mass spectrometry findings 
confirmed the diagnosis of beta-ketothiolase deficiency. Parents 
were counselled regarding the prognosis of the condition and 
explained about mild protein restriction and early treatment of 
minor illnesses.
Twin A presented 8 months later with similar symptoms. He 
was once again dehydrated with severe metabolic acidosis with 
pH 7.1, HCO3- 2.1 mmol/L, base excess -27 mmol/L, positive 
urine ketones, and hypoglycemia. He responded immediately to 
symptomatic treatment. This time parents gave a history of mild 
global developmental delay in the child which was confirmed 
by our assessment. The next day his twin brother (Twin B) was 
brought with the same symptoms. He was severely dehydrated 
with acidotic breathing. Urine ketones were large, and blood 
glucose was low. Arterial blood gas analysis showed severe 
metabolic acidosis with pH 7.08, HCO3- 3 mmol/L, and base 
excess was −25.7 mmol/L. He was also treated aggressively with 
fluid and bicarbonate correction, and hypoglycemia was corrected. 
This twin was not found to have developmental delay. Complete 
metabolic screening was sent for this twin; he also tested positive 
for beta-ketothiolase deficiency by urine gas chromatography-
mass spectrometry. Parents were counselled, and the importance 
of protein restriction and prompt treatment of minor illnesses was 
reinforced. The twins were growing well till 2 years of age after 
which they were lost to follow-up.
DISCUSSION
Beta-ketothiolase deficiency also known as mitochondrial 
acetoacetyl CoA thiolase (T2) deficiency is a rare disorder of 
ketone body and isoleucine metabolism (Fig. 1). Urinary organic 
acid analysis, even between ketoacidotic episodes, helps make 
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the diagnosis of T2 deficiency. Excessive excretion of 2-methyl-
3-hydroxybutyrate (most reliable), tiglylglycine, and 2 methyl 
acetoacetate is a typical organic acid profile of this disorder 
in urine both during and between ketoacidotic episodes [4,5]. 
However, the absence of these markers does not exclude the 
diagnosis. The gold standard for diagnosis is enzyme analysis 
and gene mutation studies, although we could not confirm the 
diagnosis by these investigations due to financial constraints.
T2 deficient patients are usually asymptomatic during the 
neonatal period. The ketoacidotic attacks usually start between 
5 months and 2 years. The classical presentation is of severe acidosis 
with loose stools and dehydration usually precipitated by a viral 
illness such as acute gastroenteritis or an upper respiratory illness, 
otitis media, prolonged fasting, or by a high protein diet. In between 
the episodes, child will be asymptomatic [4]. Other symptoms 
include polypnea, dyspnea, lethargy, or even coma and convulsions. 
This disorder can mimic an encephalitis/encephalopathy. Blood 
pH is usually <7.1, base excess <−20 mmol/L, and bicarbonate 
is usually <7 [4]. Blood glucose levels are usually normal but 
can range from hypoglycemia to hyperglycemia. Once the acute 
episode is managed, the long-term prognosis of this particular 
inborn error of metabolism is usually favorable. Parents have to be 
counselled about following 3 important things [3,4]:
1. Mild restriction of protein intake (1.5-2 g/kg/day).
2. Prolonged fasting should be avoided.
3. Any acute febrile illness or diarrhea should be promptly 
treated and foods rich in sugar should be given.
 • L-carnitine is also be supplemented.
Mild developmental delay has been reported in some patients, 
which might be sequelae of severe ketoacidotic attacks [6]. There 
are reports of patients surviving till adulthood and one report 
of a woman getting pregnant and giving birth to a normal baby 
who turned out to be a heterozygous carrier [7]. Our patients 
came with the classical presentation. The 2nd episode of Twin 
A was precipitated by fever with loose stools which lasted for 
a week. Twin B’s episode was also probably precipitated by the 
same viral illness. In retrospect, the parents also gave a history 
of giving them a high protein diet (i.e., eggs) for the first time 
that week.
CONCLUSION
What makes this inborn error of metabolism not only unique 
but also important, is that it has a favorable outcome if future 
ketoacidotic episodes can be avoided. This disorder can easily 
be missed and treated only as severe gastroenteritis with acidosis 
or kenotic hypoglycemia. Furthermore, this being an autosomal 
recessive trait, screening of family members, especially siblings, 
is of utmost importance. In the index case, the parents had refused 
screening for Twin B initially, when his brother was admitted 
due to financial constraints. This highlights the importance 
of metabolic screening in siblings. If recognized early, parents 
counselled and preventive measures are taken, children with this 
disorder can go on to live near normal lives.
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Figure 1: Summary of ketone body metabolism and isoleucine 
catabolism. 2M3HB indicates 2-methyl-3-hydroxybutyryl; 
2MAA,2-methylacetoacetyl; 3HB, 3-hydroxybutyrate; 3HBD, 
3-hydroxybutyrate; AA, acetoacetyl; AcAc, acetoacetate; CoA, 
coenzyme A; FFA, free fatty acids; HMG-CoA, 3-hydroxy-3-
methylglutarryl-CoA; HMGCL, HMG-CoA lyase; HMGCS, 
mitochondrial HMG-CoA synthase; MHBD, 2-methyl-3-
hydroxybutyryl-CoA dehydrogenase; SCOT, succinyl-CoA:3-
oxoacid CoA transferase; T2, mitochondrial acetoacetyl-CoA 
thiolase; TCA, tricarboxylic acid
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